ATR Latest Press Releases

-- December 17, 2025 --

Aptar's Bidose Nasal System Delivers CARDAMYST (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) Business Wire 5:00 PM

-- December 4, 2025 --

Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year Business Wire 5:00 PM

-- December 1, 2025 --

Aptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging Solutions Business Wire 5:00 PM

-- November 11, 2025 --

Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025 Business Wire 5:00 PM

-- October 30, 2025 --

Aptar Reports Third Quarter 2025 Results Business Wire 5:00 PM

-- October 16, 2025 --

Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker Sense, a Connected Add-On Device for Metered-Dose Inhalers Business Wire 8:00 AM

-- October 15, 2025 --

Aptar Named Among Top 100 of the 'World's Top Companies for Women 2025' by Forbes Business Wire 5:00 PM

-- September 8, 2025 --

Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength Business Wire 5:00 PM

-- September 4, 2025 --

Aptar Announces 2025 Investor Day Business Wire 5:00 PM

-- July 31, 2025 --

Aptar Reports Second Quarter 2025 Results Business Wire 5:00 PM

-- July 29, 2025 --

Aptar's First Nasal Pump Made with 52% Bio-based Material* now Available with Haleon's Otrivin Brand Business Wire 5:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software